News & Events
Strados Labs Recognized as Quarterfinalist for the Digital Health Hub Foundation: Digital Health Awards
PHILADELPHIA, PA – August 31, 2023 – Strados Labs is thrilled to announce its selection as a quarterfinalist for the prestigious 2023 Digital Health Awards, presented by the Digital Health Hub Foundation. Strados Labs was chosen as a quarterfinalist for the Best in...
New Frontiers in Respiratory Trials: AI, Lung Sounds, Remote Coaching and Alternate Endpoints
Strados Labs was featured on Clario's webinar in June about the latest advancements and technologies in respiratory trials.View the recording (only the Strados Labs' section which is about 8 minutes) presented by our Senior Machine Learning Engineer Dr. Adrian...
Clario and Strados Labs partner to bring new pulmonary endpoints to respiratory clinical trials
High-quality information about cough can be particularly difficult to assess as patient self-reporting is highly subjective and existing solutions are burdensome for both patients and researchers RESP Biosensor is the only FDA-cleared pulmonary wearable device for use...
Strados Wins the 2023 ATA Telehealth Innovators Challenge
Philadelphia, PA March 8, 2023 – Strados Labs today announced that it was named a winner in the ATA Telehealth Innovators Challenge as part of the 'Tools That Deliver Care' category. Strados was recognized for its RESP™ Biosensor, a device similar to a wearable...
RESP™ Biosensor Added to Government Contract Vehicles Through Partner, Lovell
PENSACOLA, FLORIDA, UNITED STATES, February 2, 2023 -- Strados Labs announced today that their remote monitoring solution, the Strados™ Care Respiratory Platform, which includes the RESP™ Biosensor, can now be found on the Defense Logistics Agency’s Electronic...
Strados Labs Forms Collaboration with Boehringer Ingelheim for its Idiopathic Pulmonary Fibrosis (IPF) Pilot Study
Philadelphia, PA January 26, 2023 – Strados Labs today announced a collaboration with Boehringer Ingelheim to remotely monitor patients using its FDA-cleared pulmonary wearable device in an upcoming idiopathic pulmonary fibrosis (IPF) pilot study. In Boehringer...